Management of high-risk melanoma.
Improved treatment options for patients with high-risk melanoma are of great importance for clinicians who participate in the care of these patients. There remains an overall lack of response to existing treatment options, which continues to fuel the efforts of basic scientists and clinicians to pursue other approaches for the treatment of melanoma that is no longer limited to the skin. Continued investigation into the innovative and concurrent use of surgery, chemotherapy, immunotherapy, and radiation therapy holds significant promise for improved outcomes in the management of patients with this devastating disease.
Bonaccorsi
P
P
Department of Dermatology, Emory University School of Medicine, Veterans Affairs Medical Center, Atlanta, Georgia, USA.
Ansel
J C
JC
Armstrong
C A
CA
D019496:Cancer Vaccines / Q000627:therapeutic use; D015316:Genetic Therapy; D006801:Humans; D008545:Melanoma / Q000175:diagnosis / Q000628:therapy*; D011379:Prognosis; D012307:Risk Factors; D021701:Sentinel Lymph Node Biopsy; D012878:Skin Neoplasms / Q000175:diagnosis / Q000628:therapy*
D019496:Cancer Vaccines